Vaccine News and Research

Latest Vaccine News and Research

Study highlights increase in VZV-induced CNS infections and dementia risk

Researchers from Fujita Health University, Japan, observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster virus (VZV), post-2019. The researchers highlighted the potential of zoster vaccination to reduce CNS infections.

27 Feb 2025

Researchers create mycobacteria with kill switches to improve TB vaccine safety

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the bacteria after they activate an immune response.

25 Feb 2025

Machine learning algorithm decodes immune system’s hidden data for disease detection

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of baddies.

24 Feb 2025

T cells play key role in protecting children from severe dengue

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).

24 Feb 2025

Why over 5 billion people still lack access to life-saving medical oxygen

The Lancet Global Health Commission highlights severe inequities in medical oxygen access, urging systemic reforms to ensure universal availability and affordability.

23 Feb 2025

Discovery paves way for new hepatitis B treatment

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine, and The Rockefeller University identified a vulnerability that opens the door to new treatments.

22 Feb 2025

New human antibody shows promise for Ebola virus treatment

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.

21 Feb 2025

Africa faces growing cholera crisis amid underfunded control plans

Climate change and conflict are fuelling a resurgence of cholera in Africa, with progress toward elimination undermined by chronic underfunding, according to new analysis.

21 Feb 2025

Targeted mRNA therapy shows promise for healing damaged lungs

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

21 Feb 2025

Texas measles outbreak nears 100 cases, raising concerns about undetected spread

Some private schools have shut down because of a rapidly escalating measles outbreak in West Texas. Local health departments are overstretched, pausing other important work as they race to limit the spread of this highly contagious virus.

21 Feb 2025

Breakthrough discovery unveils potential treatment for hepatitis B

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine and The Rockefeller University identified a vulnerability that opens the door to new treatments.

20 Feb 2025

Lasting impact of long COVID and the protective benefits of vaccination

Researchers explore the mental and physical health outcomes in patients with long COVID.

19 Feb 2025

Prozac's surprising immune-boosting effects could lead to new treatments for sepsis

Antidepressants like Prozac are commonly prescribed to treat mental health disorders, but new research suggests they could also protect against serious infections and life-threatening sepsis.

14 Feb 2025

Engineering safe and effective vaccinia virus vectors for next-generation vaccines

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been extensively exploited as a preventive vaccine. Despite the global eradication of smallpox in the 1980s, research efforts involving VACV have continued due to the potential threat of the variola virus being used as a bioweapon, which poses grave risks to human health.

14 Feb 2025

Vaccine News and Research

Latest Vaccine News and Research

Study highlights increase in VZV-induced CNS infections and dementia risk

Researchers create mycobacteria with kill switches to improve TB vaccine safety

Machine learning algorithm decodes immune system’s hidden data for disease detection

T cells play key role in protecting children from severe dengue

Why over 5 billion people still lack access to life-saving medical oxygen

Discovery paves way for new hepatitis B treatment

New human antibody shows promise for Ebola virus treatment

Africa faces growing cholera crisis amid underfunded control plans

Targeted mRNA therapy shows promise for healing damaged lungs

Texas measles outbreak nears 100 cases, raising concerns about undetected spread

Breakthrough discovery unveils potential treatment for hepatitis B

Lasting impact of long COVID and the protective benefits of vaccination

Prozac's surprising immune-boosting effects could lead to new treatments for sepsis

Engineering safe and effective vaccinia virus vectors for next-generation vaccines

Researchers uncover cause of persistent blood clots despite treatment

Immunocompromised individuals need regular boosters for Covid-19 protection

Clear communication and decision-making tools boost vaccination rates in older adults

Republican states claim zero abortions. A red-state doctor calls that ‘ludicrous.’

Vaccinations alone may not protect immunocompromised patients, Cambridge research shows

The growing list of human viruses: Are we prepared for the next outbreak?

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Vaccine News and Research

Latest Vaccine News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in